Journal
EUROPEAN JOURNAL OF CANCER
Volume 44, Issue 17, Pages 2627-2633Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2008.08.013
Keywords
Informed consent; Cancer clinical trials; Knowledge; Questionnaire
Categories
Ask authors/readers for more resources
The aim of this study was to explore the fulfilment of the requirements of informed consent in patients participating in cancer clinical trials, All patients consenting to a phase II or III clinical trial during one year were included (n = 325,176 women, 54%). Data were collected by a questionnaire, Quality of Informed Consent. The response rate was 87%. High levels of knowledge (>80%) were found for items concerning voluntariness, randomisation, benefits for future patients, participation in a research trial, and the right to withdraw. Less than 50% responded correctly to items about risks associated with the trial, the unproven nature of the trial and issues about insurances. High levels of perceived understanding were reported. Despite high levels of knowledge and perceived understanding in the majority of elements of informed consent, improvements are warranted regarding knowledge about risks, the unproven nature of the treatment and the duration of treatment. (C) 2008 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available